Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › 17.beta.-hydroxy-17.alpha.-methyl-5.alpha.-androstano[3,2-c]pyrazole 17-methyl ether

17.beta.-hydroxy-17.alpha.-methyl-5.alpha.-androstano[3,2-c]pyrazole 17-methyl ether

US Patent 4585765 · Granted Apr 29, 1986

Estimated economic value: $12,743,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

CaMKK-β as a target for treating cancer2018
CaMKKβ as a target for treating obesity2012
Ca2+/calmodulin-dependent protein kinase IV2006
Method for detection of micrometastatic prostate cancer2002
Method for screening a test compound for potential as an immunosuppressive drug 2002
Method for detection of breast cancer2001
Recombinant hK2 polypeptide2000
DNA encoding hK2 variant polypeptides2000
Antibodies specific for human prostate glandular kallkrein1996
Urogenital sinus derived growth inhibitory factor1993
17.beta.-Hydroxy-17.alpha.-methyl-5.alpha.-androstano-[3,2-c]pyrazole 17-methyl 1982
17.beta.-Hydroxy-17.alpha.-methyl-5.alpha.-androstano-[3,2-c]pyrazole 17-methyl 1982